TrialJournal of diabetes investigation2019

Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial.

Maryam Karimi Fard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.